Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 tat-vpr overlapping mRNA sequence is a critical genomic region in the Human Immunodeficiency Virus type 1 where the reading frames for the Trans-activator of transcription (Tat) and Viral protein R (Vpr) overlap. In the HXB2 reference genome, this overlap occurs between the 3' end of the vpr gene and the 5' end of the first tat exon (Los Alamos HIV Sequence Database, 2023). Tat is an essential regulatory protein that drastically increases the efficiency of viral transcription by binding to the TAR RNA element, while Vpr is a multifunctional protein that facilitates the nuclear import of the viral pre-integration complex and induces G2 cell cycle arrest in host cells (PubMed: 10644350, PubMed: 11133571). Because this sequence is required for the production of two vital viral proteins, it serves as an attractive target for RNA-based therapeutics such as antisense oligonucleotides and small interfering RNAs (siRNAs) (PubMed: 15103333). By binding to this specific mRNA junction, these agents can trigger RNA interference or steric hindrance, effectively reducing viral replication and slowing disease progression. However, the high mutation rate of HIV-1 poses a significant challenge, as even minor sequence variations can lead to drug resistance and therapeutic failure (PubMed: 12438600). Consequently, drug development efforts focus on identifying highly conserved motifs within this overlapping region to ensure broad efficacy across diverse viral clades.
Antisense inhibition and RNA interference-mediated degradation of viral mRNA
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 tat-vpr overlapping mRNA sequence (HIV-1 tat-vpr mRNA).